China's first Type 076 amphibious assault ship, People's Liberation Army Navy Ship (PLANS) Sichuan, completed its first navigation test mission and returned to the wharf of Hudong-Zhonghua Shipyard in east China's Shanghai on Sunday.
The PLANS Sichuan has a full-load displacement of over 40,000 tons and features a dual-island superstructure along with a full-length flight deck, making it easy to identify it.
Being a new-generation amphibious assault ship of the Chinese People's Liberation Army Navy, the vessel incorporates innovative electromagnetic catapult and arrestor technologies, enabling it to carry fixed-wing aircraft, helicopters and amphibious equipment.
The three-day sea trial tested and verified reliability and stability of the ship's power, electrical and other systems, achieving expected results. The indigenously developed vessel was put into the water in December 2024 at a launch and naming ceremony. It was given the hull number 51.
The sea trial started in Shanghai on Friday. Subsequent tests will be carried out gradually according to the overall equipment construction plan.
Chinese Navy's amphibious assault ship "Sichuan" completes first sea trial
Chinese Navy's amphibious assault ship "Sichuan" completes first sea trial
Chinese Navy's amphibious assault ship "Sichuan" completes first sea trial
South China's Guangdong Province is accelerating its transformation into an international medical tourism hub, positioning itself as a destination for patients worldwide seeking affordable, high-quality care.
The push follows a joint initiative announced in late March by nine Chinese government departments, including the Ministry of Commerce, aimed at boosting spending by foreign tourists and enhancing exports of tourism services as part of broader efforts to expand the country's service sector.
Every day, some of the most complex surgeries are performed here. Li Zilun, deputy director of the division of vascular surgery at the First Affiliated Hospital of Sun Yat‑sen University, is among the doctors capable of carrying out these intricate procedures.
He recently completed surgery on a patient with an aortic aneurysm, a condition often described as a "time bomb" in the body’s main artery, increasingly common in aging societies around the globe. Li also specializes in highly difficult and pioneering procedures, including repairing leaks caused by failed grafts.
"This was a very challenging case. And then, we implanted the covered stent to eliminate the endoleak. Actually, the outcome was pretty good. The patient will be discharged today," said Li Zilun.
The ability to handle such complex cases -- combining international techniques with domestically produced devices -- is drawing patients from around the world to seek treatment. In addition, high safety standards and low costs are also major draws.
"Our government is encouraging innovation. So, lots of physicians -- including our vascular surgeons -- we are actively involved in the innovation that helps to increase the effectiveness and safety, and also bring down the cost," said Li.
This hospital is one of the first in Guangdong to be designated by the provincial health commission as a pilot site for building an international medical service hub.
The growing number of patients has pushed the hospital to explore new ways to transform every step -- from treatment to payment and everything in between -- into a seamless experience, reducing waiting times and delivering better care for patients.
"I think it's fast. When the patient come here for just about, I think, one week, you can solve the problem," said Xiao Haipeng, president of the First Affiliated Hospital of Sun Yat-sen University.
The hospital is also deepening its international cooperation with top-tier medical institutions, including those at Harvard University.
"Not just for China, for the whole globe, we are facing health care challenges -- emerging infectious disease and chronic, lung infectious diseases, and also the aging population, also the shortage of healthcare workforce," said Xiao.
In response to these challenges, China is promoting its own solutions, including aggressive innovation in artificial intelligence (AI)-driven workflows, while stepping up research and development investment and global engagement along the way.
"In recent years, the innovation in Western medicine is dramatically growing. An example of my hospital -- in the past few years, we have 140 innovations and seven of them are international leading innovations," said Xiao.
As global demand for medical tourism grows, China is positioning itself as a new destination. Official data shows that the number of foreign patients in Guangdong increased by 20 percent last year. Among them, the growth in inpatient admissions was even faster, rising by 76 percent.
Guangdong fast-tracks pilot for int'l medical service hub
